GlassScriptPhysician profile
Kimberly Glenn
NPI 1659601649
$1,247.73
in general payments reported to CMS, 2019-2025
17 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $80.03 · 2023: $154 · 2024: $261 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.21 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $386.11 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $241.98 | 2021-2025 | Mounjaro, Zepbound |
| Antares Pharma, INC. | $111.10 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Amgen INC. | $78.92 | 2021-2024 | Repatha, Otezla |
| Pfizer INC. | $62.91 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $58.93 | 2021-2024 | Airsupra |
| Glaxosmithkline, LLC. | $44.09 | 2024 | Trelegy Ellipta, Arexvy |
| Esperion Therapeutics, INC. | $38.01 | 2025 | Nexletol |
| Halozyme INC | $37.96 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.99 | 2021 | |
| Astellas Pharma US INC | $25.82 | 2024 | Veozah |
| Eisai INC. | $25.76 | 2021 | |
| Abbvie INC. | $24.30 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.93 | 2022 | |
| Exact Sciences Corporation | $19.29 | 2025 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.24 | 2021 | |
| Merck Sharp & Dohme LLC | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Glenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.